TIRR regulates 53BP1 by masking its histone methyl-lysine binding function

Archive ouverte

Drané, Pascal | Brault, Marie-Eve | Cui, Gaofeng | Meghani, Khyati | Chaubey, Shweta | Detappe, Alexandre | Parnandi, Nishita | He, Yizhou | Zheng, Xiao-Feng | Botuyan, Maria | Kalousi, Alkmini | Yewdell, William | Münch, Christian | Harper, J | Chaudhuri, Jayanta | Soutoglou, Evi | Mer, Georges | Chowdhury, Dipanjan

Edité par CCSD ; Nature Publishing Group -

P53-binding protein 1 (53BP1) is a multi-functional double-strand break repair protein that is essential for class switch recombination in B lymphocytes and for sensitizing BRCA1-deficient tumours to poly-ADP-ribose polymerase-1 (PARP) inhibitors. Central to all 53BP1 activities is its recruitment to double-strand breaks via the interaction of the tandem Tudor domain with dimethylated lysine 20 of histone H4 (H4K20me2). Here we identify an uncharacterized protein, Tudor interacting repair regulator (TIRR), that directly binds the tandem Tudor domain and masks its H4K20me2 binding motif. Upon DNA damage, the protein kinase ataxia-telangiectasia mutated (ATM) phosphorylates 53BP1 and recruits RAP1-interacting factor 1 (RIF1) to dissociate the 53BP1-TIRR complex. However, overexpression of TIRR impedes 53BP1 function by blocking its localization to double-strand breaks. Depletion of TIRR destabilizes 53BP1 in the nuclear-soluble fraction and alters the double-strand break-induced protein complex centring 53BP1. These findings identify TIRR as a new factor that influences double-strand break repair using a unique mechanism of masking the histone methyl-lysine binding function of 53BP1.

Consulter en ligne

Suggestions

Du même auteur

DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells

Archive ouverte | He, Yizhou Joseph | CCSD

International audience

Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance–Computed Tomography Image Guided Radiation Therapy

Archive ouverte | Detappe, Alexandre | CCSD

International audience. Selective killing of cancer cells while minimizing damage to healthy tissues is the goal of clinical radiation therapy. This therapeutic ratio can be improved by image-guided radiation delive...

Key clinical beam parameters for nanoparticle-mediated radiation dose amplification

Archive ouverte | Detappe, Alexandre | CCSD

International audience. As nanoparticle solutions move towards human clinical trials in radiation therapy, the influence of key clinical beam parameters on therapeutic efficacy must be considered. In this study, we ...

Chargement des enrichissements...